clinical trial

Gene editing CRISPR gene therapy
Biotech

After 2 undisclosed deaths, can China’s IIT still be trusted?

Seeing the deaths as proof that the investigator-initiated trials (IIT) pathway is unreliable ignores new guardrails added by China, experts told Fierce.
Angus Liu , Darren Incorvaia Aug 17, 2026 7:20am
Lung

Sanofi suspends chronic lung disease phase 2 study

Aug 5, 2026 2:50pm
Becraft

Strand Tx CEO Jake Becraft weighs in on FDA's IND reform, China

May 4, 2026 12:00pm
IV

Takeda drug improves convenience for PID patients in pivotal trial

May 4, 2026 10:48am
topic report
Makary
Favicon Fierce Pharma

FDA's Makary shares policy requests with Congress

Apr 7, 2026 11:04am
Test tube pipette

CRO Fortrea launches AI solution to improve trial efficiency

Apr 7, 2026 11:01am